Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL-HIV trial: DATASET

Autor: Sculier, Delphine, Wandeler, Gilles, Yerly, Sabine, Marinosci, Annalisa, Stoeckle, Marcel, Bernasconi, Enos, Braun, Dominique L, Vernazza, Pietro, Cavassini, Matthias, Buzzi, Marta, Metzner, Karin J, Decosterd, Laurent, Günthard, Huldrych F, Schmid, Patrick, Limacher, Andreas, Egger, Matthias, Calmy, Alexandra, Swiss HIV, Cohort Study
Jazyk: angličtina
Rok vydání: 2020
Předmět:
DOI: 10.7892/boris.146808
Databáze: OpenAIRE